iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report)’s stock price traded up 1.9% during trading on Wednesday . The stock traded as high as $32.79 and last traded at $32.79. 155 shares traded hands during trading, a decline of 89% from the average session volume of 1,366 shares. The stock had previously closed at $32.17.
iShares Neuroscience and Healthcare ETF Stock Up 1.9%
The company has a market capitalization of $4.92 million, a PE ratio of 15.61 and a beta of 0.93. The stock’s fifty day moving average price is $31.66 and its two-hundred day moving average price is $27.86.
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.
Read More
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- A month before the crash
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Your Bank Account Is No Longer Safe
- Bitcoin is down but your income is about to explode
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
